Solriamfetol hydrochloride
产品编号: DC11529
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Solriamfetol (JZP-110) 是一种选择性多巴胺和去甲肾上腺素再摄取抑制剂,具有强大的唤醒促进作用。Solriamfetol 可与多巴胺和去甲肾上腺素转运蛋白结合,进而可以抑制多巴胺和去甲肾上腺素的再摄取。Solriamfetol 显着提高了患有嗜睡症的成年人保持清醒的能力和过度嗜睡的主观症状。
Cas No.: |
178429-62-4 |
名称: |
|
别名: |
JZP-110;R-228060;ADX-N05;YKP-10A |
SMILES: |
C1C=CC(C[C@H](N)COC(N)=O)=CC=1.Cl |
分子式: |
C10H15ClN2O2 |
分子量: |
230.692 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
Solriamfetol hydrochloride (JZP-110, R-228060, ADX-N05, YKP-10A) is a norepinephrine-dopamine reuptake inhibitor that inhibits dopamine and norepinephrine transporter with IC50 of 2.9 and 4.4 uM, respectively; a wake-promoting agent with dopaminergic and noradrenergic activity. |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
TITLE |
DOWNLOAD |
MSDS_823_DC11529_178429-62-4 |
|
COA
LOT NO. |
DOWNLOAD |
|
|
询盘